iBio, Inc. Common Stock (IBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $51.55M
Last updated: Nov 17, 2026 at 11:06 AM ET
iBio, Inc. Common Stock (IBIO) Earnings: Report Dates and Results
iBio, Inc. Common Stock (IBIO) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, iBio, Inc. Common Stock reported EPS of -$0.05, above the -$0.07 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IBIO has an expected report date of Feb 8, 2027.
Earnings History
Of the 22 quarters below that had an estimate, IBIO beat 9, missed 11 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2022, when EPS landed 221.71% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.05 | -$0.07 | -$0.10 - -$0.05 | +28.57% | Beat | N/A | 7 | 0 up, 0 down | Nov 10, 2026 | N/A |
| Jun 30, 2026 | -$0.04 | -$0.07 | -$0.09 - -$0.03 | +42.86% | Beat | N/A | 7 | 1 up, 0 down | Aug 28, 2026 | N/A |
| Mar 31, 2026 | -$0.06 | -$0.06 | -$0.07 - -$0.04 | -2.05% | Miss | N/A | 6 | 0 up, 1 down | May 12, 2026 | N/A |
| Dec 31, 2025 | -$0.09 | -$0.06 | -$0.07 - -$0.06 | -50.00% | Miss | N/A | 2 | 0 up, 0 down | Feb 10, 2026 | N/A |
| Sep 30, 2025 | -$0.29 | -$0.43 | N/A | +32.56% | Beat | N/A | 3 | 0 up, 0 down | Nov 12, 2025 | $100000 |
| Jun 30, 2025 | -$0.32 | -$0.36 | -$0.39 - -$0.34 | +11.11% | Beat | N/A | 2 | 0 up, 0 down | Sep 5, 2025 | $200000 |
| Mar 31, 2025 | -$0.49 | -$0.32 | -$0.39 - -$0.25 | -53.13% | Miss | N/A | 2 | 0 up, 0 down | May 2, 2025 | N/A |
| Dec 31, 2024 | -$0.48 | -$0.46 | -$0.51 - -$0.43 | -4.35% | Miss | N/A | 2 | 0 up, 0 down | Feb 10, 2025 | $200000 |
| Sep 30, 2024 | -$0.46 | -$0.46 | -$0.53 - -$0.43 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$0.90 | -$0.47 | -$0.48 - -$0.46 | -91.89% | Miss | N/A | 2 | 0 up, 0 down | Sep 25, 2024 | $175000 |
| Mar 31, 2024 | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2024 | N/A |
| Dec 31, 2023 | -$4.42 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Feb 9, 2024 | N/A |
| Sep 30, 2023 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Nov 14, 2023 | $50000 |
| Jun 30, 2023 | -$1.80 | -$8.20 | N/A | +78.05% | Beat | N/A | N/A | N/A | Sep 27, 2023 | N/A |
| Mar 31, 2023 | -$11.00 | -$7.20 | N/A | -52.78% | Miss | N/A | 1 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$21.60 | -$12.50 | N/A | -72.80% | Miss | N/A | 1 | 0 up, 0 down | Feb 14, 2023 | N/A |
| Sep 30, 2022 | -$112.60 | -$35.00 | N/A | -221.71% | Miss | N/A | 2 | 0 up, 0 down | Oct 11, 2022 | N/A |
| Jun 30, 2022 | -$1.96 | -$2.12 | -$2.25 - -$2.00 | +7.55% | Beat | -19700.0% | 2 | 0 up, 0 down | Sep 27, 2022 | $61000 |
| Mar 31, 2022 | -$30.00 | -$27.50 | -$30.00 - -$25.00 | -9.09% | Miss | N/A | 2 | 0 up, 0 down | May 12, 2022 | $1.80M |
| Dec 31, 2021 | -$25.00 | -$20.00 | -$20.00 - -$20.00 | -25.00% | Miss | N/A | 2 | 0 up, 0 down | Feb 14, 2022 | N/A |
| Sep 30, 2021 | -$1.00 | -$1.25 | -$1.25 - -$1.25 | +20.00% | Beat | N/A | 1 | N/A | Nov 15, 2021 | $84000 |
| Jun 30, 2021 | $0.01 | -$20.00 | N/A | +100.05% | Beat | N/A | N/A | N/A | Sep 27, 2021 | $491000 |
| Mar 31, 2021 | -$20.00 | -$20.00 | N/A | 0.00% | In line | N/A | N/A | N/A | May 17, 2021 | $765000 |
| Dec 31, 2020 | -$20.00 | -$17.50 | N/A | -14.29% | Miss | N/A | 1 | N/A | Feb 16, 2021 | $705000 |
| Sep 30, 2020 | -$10.00 | -$25.00 | N/A | +60.00% | Beat | N/A | 1 | N/A | Oct 13, 2020 | $410000 |
| Mar 31, 2020 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2020 | $96000 |
| Dec 31, 2019 | -$0.69 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2020 | $314000 |
| Sep 30, 2019 | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 | $108000 |
| Jun 30, 2019 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 26, 2019 | $795000 |
| Mar 31, 2019 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2019 | $527000 |
| Dec 31, 2018 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 13, 2019 | $651000 |
| Sep 30, 2018 | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2018 | $45000 |
| Jun 30, 2018 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 18, 2018 | $91000 |
| Mar 31, 2018 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 11, 2018 | $78000 |
| Dec 31, 2017 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2018 | $153000 |
| Sep 30, 2017 | -$0.42 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2017 | $122000 |
| Jun 30, 2017 | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 15, 2017 | $147000 |
| Mar 31, 2017 | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 15, 2017 | $37000 |
| Dec 31, 2016 | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 21, 2017 | $75000 |
| Sep 30, 2016 | -$0.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 13, 2016 | $135000 |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$0.48, after -$1.75 the year before. It was -$599.22 for the year ended Jun 30, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$0.48 | N/A |
| Jun 30, 2025 | -$1.75 | N/A |
| Jun 30, 2024 | -$6.42 | N/A |
| Jun 30, 2023 | -$147.00 | N/A |
| Jun 30, 2022 | -$57.96 | N/A |
| Jun 30, 2021 | -$50.95 | N/A |
| Jun 30, 2019 | -$0.94 | N/A |
| Jun 30, 2018 | -$1.56 | N/A |
| Jun 30, 2017 | -$1.64 | N/A |
| Jun 30, 2016 | -$599.22 | N/A |
Frequently Asked Questions About IBIO
When is iBio, Inc. Common Stock's next earnings date?
iBio, Inc. Common Stock's next earnings report is expected for Feb 8, 2027.
Did IBIO beat earnings estimates last quarter?
Yes. iBio, Inc. Common Stock reported EPS of -$0.05 for the quarter ended Sep 30, 2026, above the -$0.07 estimate, a 28.57% surprise.
What EPS do analysts expect from IBIO next quarter?
The consensus EPS estimate for iBio, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.06 from 3 analysts, with estimates from -$0.07 to -$0.05.
How often does IBIO beat earnings estimates?
iBio, Inc. Common Stock beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.70%.
IBIO pages: Overview, Earnings, Forecast, Financials, Competitors